Skip to main content

BioXcel Therapeutics, Inc.

BTAIQ
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001720893

No open-market purchases or sales by BioXcel Therapeutics, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $8.69M in total; Oaktree Capital is the only superinvestor holding it.

13F holders, Q4 2025

Institutional positions in BioXcel Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
41
+7 vs. Q3 2025
Shares held
3.54M
+1.18M (+50.0%) vs. Q3 2025
Total value
$5.66M
−$388.6K (−6.4%) vs. Q3 2025
New holders
11
11 more added
Sold out
4
7 more reduced

1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting BTAIQ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2025: 41 institutions
Q1 2021: 118 institutionsQ2 2021: 109 institutionsQ3 2021: 104 institutionsQ4 2021: 93 institutionsQ1 2022: 96 institutionsQ2 2022: 94 institutionsQ3 2022: 85 institutionsQ4 2022: 84 institutionsQ1 2023: 97 institutionsQ2 2023: 88 institutionsQ3 2023: 86 institutionsQ4 2023: 73 institutionsQ1 2024: 74 institutionsQ2 2024: 74 institutionsQ3 2024: 50 institutionsQ4 2024: 49 institutionsQ1 2025: 31 institutionsQ2 2025: 35 institutionsQ3 2025: 35 institutionsQ4 2025: 41 institutionsQ1 2026: 40 institutionsQ2 2026: 47 institutions
Value heldQ4 2025: $5.66M
Q1 2021: $475.2MQ2 2021: $378.6MQ3 2021: $388.3MQ4 2021: $283.1MQ1 2022: $273.9MQ2 2022: $167.4MQ3 2022: $140.3MQ4 2022: $288.9MQ1 2023: $325.0MQ2 2023: $117.8MQ3 2023: $25.8MQ4 2023: $27.6MQ1 2024: $26.1MQ2 2024: $12.5MQ3 2024: $1.89MQ4 2024: $3.22MQ1 2025: $769.7KQ2 2025: $1.09MQ3 2025: $6.05MQ4 2025: $5.66MQ1 2026: $7.28MQ2 2026: $8.69M
Institutions holding BTAIQ and their total value by quarter
QuarterHoldersValue
Q2 202647$8.69M
Q1 202640$7.28M
Q4 202541$5.66M
Q3 202535$6.05M
Q2 202535$1.09M
Q1 202531$769.7K
Q4 202449$3.22M
Q3 202450$1.89M
Q2 202474$12.5M
Q1 202474$26.1M
Q4 202373$27.6M
Q3 202386$25.8M
Q2 202388$117.8M
Q1 202397$325.0M
Q4 202284$288.9M
Q3 202285$140.3M
Q2 202294$167.4M
Q1 202296$273.9M
Q4 202193$283.1M
Q3 2021104$388.3M
Q2 2021109$378.6M
Q1 2021118$475.2M

Institutions, Q4 2025

Shares, value and share of portfolio for each institution holding BioXcel Therapeutics, Inc.; share changes are against Q3 2025.

Institutions holding BTAIQ in Q4 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Millennium Management LLC1,835,192$2.94M0.00%+807,139+78.5%Added
Vanguard Group Inc292,753$468.4K0.00%+100,628+52.4%Added
Oaktree Capital Management LPSuperinvestorOaktree Capital241,188$385.9K0.01%00.0%Unchanged
Geode Capital Management, LLC206,168$329.9K0.00%+80,928+64.6%Added
Jones Financial Companies LLLP137,690$220.3K0.00%+101,690+282.5%Added
Jane Street Group, LLC127,501$204.0K0.00%+127,501New
Gsa Capital Partners LLP120,102$192.0K0.02%+120,102New
FMR LLC90,300$144.5K0.00%−108,300−54.5%Reduced
BlackRock, Inc.84,396$135.0K0.00%+114+0.1%Added
State Street Corp63,218$101.1K0.00%+10,500+19.9%Added
Man Group plc56,825$90.9K0.00%+56,825New
Oaktree Fund Advisors, LLC42,913$68.7K0.13%00.0%Unchanged
HighTower Advisors, LLC41,000$65.6K0.00%+6,000+17.1%Added
Northern Trust Corp38,370$61.4K0.00%+637+1.7%Added
UBS Group AG38,340$61.3K0.00%−5,202−11.9%Reduced
Diversify Wealth Management, LLC15,000$30.8K0.00%00.0%Unchanged
HRT Financial LP18,062$28.0K0.00%+18,062New
Two Sigma Securities, LLC17,068$27.3K0.00%+17,068New
Advisor Group Holdings, Inc.15,749$25.2K0.00%+666+4.4%Added
Engineers Gate Manager LP12,303$19.7K0.00%+12,303New
Portfolio Strategies, Inc.12,178$19.5K0.00%+12,178New
Citigroup Inc12,079$19.3K0.00%+11,724+3,302.5%Added
IFP Advisors, Inc4,370$6.99K0.00%00.0%Unchanged
Wells Fargo & Company4,325$6.92K0.00%−11,991−73.5%Reduced
Group One Trading, L.P.3,185$5.10K0.00%+936+41.6%Added
Caitong International Asset Management Co., Ltd1,642$2.63K0.00%+1,642New
Morgan Stanley1,464$2.34K0.00%−177−10.8%Reduced
Bank of America Corp1,446$2.31K0.00%−5,435−79.0%Reduced
GWM Advisors LLC1,331$2.13K0.00%00.0%Unchanged
SBI Securities Co., Ltd.169$2700.00%00.0%Unchanged
Washington Trust Advisors, Inc.160$2560.00%00.0%Unchanged
Parkside Financial Bank & Trust112$1800.00%00.0%Unchanged
Annis Gardner Whiting Capital Advisors, LLC112$1800.00%+112New
EverSource Wealth Advisors, LLC60$960.00%00.0%Unchanged
JPMorgan Chase & Co45$720.00%00.0%Unchanged
Farther Finance Advisors, LLC25$400.00%+25New
Northwestern Mutual Wealth Management Co21$340.00%00.0%Unchanged
BNP Paribas Arbitrage, SA12$190.00%−27−69.2%Reduced
Zurcher Kantonalbank (Zurich Cantonalbank)2$30.00%−101−98.1%Reduced
US Bancorp1$20.00%00.0%Unchanged
Triumph Capital Management1$20.00%+1New
XTX Topco Ltd0$00.00%−113,364−100.0%Sold out
Foundations Investment Advisors, LLC0$00.00%−29,549−100.0%Sold out
SLT Holdings LLC0$00.00%−29,500−100.0%Sold out
Tower Research Capital LLC (TRC)0$00.00%−3,933−100.0%Sold out
AllSquare Wealth Management LLC––––Not filed